Your browser doesn't support javascript.
loading
Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations.
Wedzicha, J A; Singh, D; Vestbo, J; Paggiaro, P L; Jones, P W; Bonnet-Gonod, F; Cohuet, G; Corradi, M; Vezzoli, S; Petruzzelli, S; Agusti, A.
Afiliação
  • Wedzicha JA; National Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address: j.wedzicha@imperial.ac.uk.
  • Singh D; Medicines Evaluation Unit, South Manchester University Hospital, Manchester, United Kingdom.
  • Vestbo J; Respiratory & Allergy Research Group, Manchester Academic Health Sciences Centre, South Manchester University Hospital, Manchester, United Kingdom.
  • Paggiaro PL; Cardio-Thoracic and Vascular Department, University Hospital of Pisa, Italy.
  • Jones PW; Clinical Science, St. George's University of London, United Kingdom.
  • Bonnet-Gonod F; Chiesi Farmaceutici, Courbevoie, France.
  • Cohuet G; Chiesi Farmaceutici, Courbevoie, France.
  • Corradi M; Department of Clinical and Experimental Medicine, University of Parma, Italy.
  • Vezzoli S; Chiesi Farmaceutici, Parma, Italy.
  • Petruzzelli S; Chiesi Farmaceutici, Parma, Italy.
  • Agusti A; Institut del Tòrax, Hospital Clinic, Univ. Barcelona, Spain.
Respir Med ; 108(8): 1153-62, 2014 Aug.
Article em En | MEDLINE | ID: mdl-24953015

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Broncodilatadores / Beclometasona / Doença Pulmonar Obstrutiva Crônica / Etanolaminas / Glucocorticoides Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Broncodilatadores / Beclometasona / Doença Pulmonar Obstrutiva Crônica / Etanolaminas / Glucocorticoides Idioma: En Ano de publicação: 2014 Tipo de documento: Article